Ernexa Therapeutics Inc.
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
ERNA$2.05+9.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
Exhibits*
| Exhibit | Description | Incorporated By Reference |
| 3.1 | Certificate of Amendment to the Company’s Restated Certificate of Incorporation, effective March 26, 2025 (Name Change). | Exhibit 3.1 to Form 8k filed on March 26, 2025 |
| 3.2 | Third Amended and Restated Bylaws of the Company | Exhibit 3.2 to Form 8k filed on March 26, 2025 |
| 10.1 | Securities purchase agreement, dated as of March 31, 2025, between Ernexa Therapeutics Inc. and the purchaser parties thereto | Exhibit 10.1 to Form 8k filed on April 3, 2025 |
| 10.2 | Registration rights agreement, dated as of March 31, 2025, between Ernexa Therapeutics Inc. and the purchaser parties thereto | Exhibit 10.2 to Form 8k filed on April 3, 2025 |
| 10.3 | Form of pre-funded warrant issuable under the securities purchase agreement, dated as of March 31, 2025, between Ernexa Therapeutics Inc. and the purchaser parties thereto | Exhibit 10.3 to Form 8k filed on April 3, 2025 |
| 10.4 | Promissory note, dated as March 20, 2025, between Eterna Therapeutics Inc. and Charles Cherington | Exhibit 10.1 to Form 8k filed on March 24, 2025 |
| 10.5 | Promissory note, dated as March 11, 2025, between Eterna Therapeutics Inc. and Charles Cherington | Exhibit 10.1 to Form 8k filed on March 12, 2025 |
| 31.1 | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | Filed herewith |
| 31.2 | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | Filed herewith |
| 32.1 | Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | Furnished herewith |
| 32.2 | Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | Furnished herewith |
| 101 | Inline XBRL Document Set for the financial statements and accompanying notes in Part I, Item 1, of this Quarterly Report on Form 10-Q.. | Filed herewith |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.